The Court granted bail in a case concerning spurious cancer drugs under the PMLA, citing insufficient evidence linking the proceeds of crime to a predicate offence.
Bail Granted in Cancer Drug Case Under PMLA
The Court has granted bail in a high-profile case involving spurious cancer drugs under the Prevention of Money Laundering Act (PMLA). The main factor in the grant of bail was the lack of a clear link between the alleged proceeds of crime and the predicate offence, which the Enforcement Directorate (ED) failed to substantiate.
The ruling pointed out that the investigation did not adequately explore the roles of healthcare professionals and institutions involved in the distribution of these alleged fraudulent drugs. The absence of this crucial evidence was pivotal in the Court's decision to grant bail.
This judgment serves as a reminder of the necessity for thorough investigations and the evidentiary burden on the prosecution under the PMLA, particularly in complex cases involving healthcare fraud. Practitioners should consider the implications for future enforcement actions and the importance of comprehensive evidence gathering.
Citations
- PMLA Special Court (2026) 0 PMLA 0
